TL;DR: This week, the first university biomedical intellectual property (IP) and research project was funded as an NFT (non-fungible token), enabled by a pioneering innovation at Molecule. The IP-NFT enables new fundraising and collaboration strategies for researchers by combining legal and technical frameworks with NFT technology. Early-stage research can be financed without endless grant applications, creating a startup and raising VC or needing to file a patent.

A blossoming Decentralized Science (DeSci) movement is changing the biopharma landscape by enabling the formation of patient- and researcher-centric communities building with an open-source ethos.

On a recent episode of The DeSci Podcast, Vincent Weisser interviewed Vitalk Buterin, co-founder of the Ethereum Foundation, to talk about the state of decentralized science today and its prospects for the future which led to an in-depth analysis of the potential curveballs and unknowns.